Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.

P. Pinge-Filho,J. Peron,T. R. de Moura,R. A. Menolli,V. K. Graça,D. Estevão,C. Tadokoro,J. V. Jankevicius,L. Rizzo

DOI: https://doi.org/10.1016/J.IMLET.2004.09.010

IF: 4.23

2005-01-31

Immunology Letters

Abstract:

What problem does this paper attempt to address?

Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

Saloni Agarwal,Christian Warmt,Joerg Henkel,Livia Schrick,Andreas Nitsche,Frank F. Bier

DOI: https://doi.org/10.1007/s00216-022-03880-4

2022-01-19

Analytical and Bioanalytical Chemistry

Abstract:Abstract The degree of detrimental effects inflicted on mankind by the COVID-19 pandemic increased the need to develop ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free, and Deliverable) POCT (point of care testing) to overcome the current and any future pandemics. Much effort in research and development is currently advancing the progress to overcome the diagnostic pressure built up by emerging new pathogens. LAMP (loop-mediated isothermal amplification) is a well-researched isothermal technique for specific nucleic acid amplification which can be combined with a highly sensitive immunochromatographic readout via lateral flow assays (LFA). Here we discuss LAMP-LFA robustness, sensitivity, and specificity for SARS-CoV-2 N-gene detection in cDNA and clinical swab-extracted RNA samples. The LFA readout is designed to produce highly specific results by incorporation of biotin and FITC labels to 11-dUTP and LF (loop forming forward) primer, respectively. The LAMP-LFA assay was established using cDNA for N-gene with an accuracy of 95.65%. To validate the study, 82 SARS-CoV-2-positive RNA samples were tested. Reverse transcriptase (RT)-LAMP-LFA was positive for the RNA samples with an accuracy of 81.66%; SARS-CoV-2 viral RNA was detected by RT-LAMP-LFA for as low as CT-33. Our method reduced the detection time to 15 min and indicates therefore that RT-LAMP in combination with LFA represents a promising nucleic acid biosensing POCT platform that combines with smartphone based semi-quantitative data analysis. Graphical abstract

chemistry, analytical,biochemical research methods
RT-LAMP Assay Combining Multi-Fluorescent Probes for SARS-CoV-2 RNA Detection and Variant Differentiation

Jadera Talap,Minzhe Shen,Lushan Yu,Su Zeng,Sheng Cai

DOI: https://doi.org/10.1016/j.talanta.2022.123644

2022-01-01

SSRN Electronic Journal

Abstract:Simple and accurate testing tools for SARS-CoV-2 viral RNA detection are essential for the prevention of the spread of the virus and timely governmental actions. Herein, we present a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the simultaneous detection of ORF1ab and N gene fragments of SARS-CoV-2 in one pot. Using two primer sets and two molecular beacon (MB) probes respectively labelled with different fluorophore, positive results were obtained with a limit of detection of 20 and 2 copies/μL for ORF1ab and N gene fragments, respectively. Moreover, the RT-LAMP based assay was applied to detect single-site differences in S genes using two one-step displacement (OSD) probes targeting wild-type and mutant (P681R mutation was chosen as model) genes. Through that, the wild type strain and P681R mutant variant were well distinguished from each other, and a preliminary observation was also made on other mutations at this site such as P681H. The proposed method has high sensitivity for quantification and high specificity for mutation differentiation. In addition, it does not require accurate sophisticated thermal cycler instrumentation and can be used in clinical settings in resource-limited regions.
Enhanced selective discrimination of point-mutated viral RNA through false amplification regulatory direct insertion in rolling circle amplification

Hakbeom Lee,Juneseok You,Hansol Lee,Woojoo Kim,Kuewhan Jang,Jinsung Park,Sungsoo Na

DOI: https://doi.org/10.1016/j.bios.2024.116145

IF: 12.545

2024-05-01

Biosensors and Bioelectronics

Abstract:Coronaviruses are single-stranded RNA viruses with high mutation rates. Although a diagnostic method for coronaviruses has been developed, variants appear rapidly. Low test accuracy owing to single-point mutations is one of the main factors in the failure to prevent the early spread of coronavirus infection. Although reverse transcription-quantitative polymerase chain reaction can detect coronavirus infection, it cannot exclude the possibility of false positives, and an additional multiplexing kit is needed to discriminate single nucleotide polymorphism (SNP) variants. Therefore, in this study, we introduced a new nucleic acid amplification method to determine whether an infected person has a SNP mutation using a lateral flow assay (LFA) as a point-of-care test. Unlike traditional DNA amplification methods, direct insertion into rolling circle amplification amplifies the target genes without false amplification. After SNP-selective nucleic acid amplification, nuclease enzymes are used to make double-stranded DNA fragments that the LFA can detect, where specific mismatched DNA is found and cleaved to show different signals when a SNP-type is present. Therefore, wild- and SNP-type variants can be selectively detected. In this study, the limit of detection was 400 aM for viral RNA, and we successfully identified a dominant SNP variant selectively. Clinical tests were also conducted.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
Rapid and Accurate Detection of Three Genes in SARS-CoV-2 Using RT-LAMP Method

Weihua Yang,Xiaofei Dang,Qingxi Wang,Mingjie Xu,Qianqian Zhao,Yunying Zhou,Huailong Zhao,Li Wang,Yihui Xu,Jun Wang,Shuyi Han,Min Wang,Huanjie Li,Fenyan Pei,Yunshan Wang

DOI: https://doi.org/10.21203/rs.3.rs-28070/v1

2020-01-01

Abstract:Abstract Background Corona Virus Disease 2019 (COVID-19) is a recently emerged life-threatening disease caused by SARS-CoV-2. It has the characteristics of rapid transmission, difficult treatment, rapid deterioration, and high mortality rate. Reliable and rapid diagnosis of SARS-CoV-2 infection is critical to treat patients and control transmission in time. Methods To detect SARS-CoV-2 nucleic acid faster and more convenient, RT-LAMP method (reverse transcription loop-mediated isothermal amplification) was developed. ORF1ab gene, E gene and N gene were selected as the target genes, because ORF1ab gene is the most specific and N gene is the most sensitive, while E gene has both sensitivity and specificity. Over thirty primer sets for them were designed, then the primer sets with rapid response and high specificity were screened out and their loop primers were designed and selected in order to improve the reaction speed further. Using these primers, RNA reverse transcription and nucleic acid amplification were performed in one step at 63 ℃ isothermal conditions, and the results can be judged by naked eyes through color change within 30 minutes. Finally, the optimal primer set for each gene was verified with over 208 clinical samples. Results ORF1ab gene, E gene and N gene were detected simultaneously by this method. ORF1ab gene has high specificity and the same sensitivity as RT-PCR currently used in clinic. Although N gene is less specific than ORF1ab, it is 80 times more sensitive than ORF1ab. The sensitivity and specificity of E gene are between them. Simultaneous detection of these three genes can neither cause false positives nor miss samples with low virus concentration, ensuring the sensitivity and specificity of SARS-CoV-2 detection. BLAST comparing results showed the primers for the three genes were highly specific for SARS-CoV-2. And the sequencing results of RT-LAMP products showed that the amplified fragments were unique to SARS-CoV-2. The accuracy of RT-LAMP assay was 99% as detecting 208 clinical specimens. Conclusions The RT-LAMP assay reported here has the advantages of rapid amplification, simple operation, and easy detection, which is useful for the rapid and reliable clinical diagnosis of SARS-CoV-2.
A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2

Narin Thippornchai,Sukanya Pengpanich,Wansadaj Jaroenram,Nathamon Kosoltanapiwat,Passanesh Sukphopetch,Wansika Kiatpathomchai,Pornsawan Leaungwutiwong

DOI: https://doi.org/10.1038/s41598-024-72417-9

2024-09-20

Abstract:The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered global difficulties for both individuals and economies, with new variants continuing to emerge. The Delta variant of SARS-CoV-2 remains most prevalent worldwide, and it affects the efficacy of coronavirus disease 2019 (COVID-19) vaccination. Expedited testing to detect the Delta variant of SARS-CoV-2 and monitor viral transmission is necessary. This study aimed to develop and evaluate a colorimetric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) technique targeting the L452R mutation in the S gene for the specific detection of the Delta variant. In the test, positivity was indicated as a color change from purple to yellow. The assay's 95% limit of detection was 57 copies per reaction for the L452R (U1355G)-specific standard plasmid. Using 126 clinical samples, our assay displayed 100% specificity, 97.06% sensitivity, and 98.41% accuracy in identifying the Delta variant of SARS-CoV-2 compared to real-time RT-PCR. To our knowledge, this is the first colorimetric RT-LAMP assay that can differentiate the Delta variant from its generic SARS-CoV-2, enabling it as an approach for studying COVID-19 demography and facilitating proper effective control measure establishment to fight against the reemerging variants of SARS-CoV-2 in the future.
One-pot, ultrasensitive, and multiplex detection of SARS-CoV-2 genes utilizing self-priming hairpin-mediated isothermal amplification

Yan Li,Taejoon Kang,Hyun Gyu Park

DOI: https://doi.org/10.1016/j.bios.2023.115522

IF: 12.545

2023-07-08

Biosensors and Bioelectronics

Abstract:The global pandemic resulting from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants highlights the need for convenient and accurate detection protocols to facilitate timely prevention and management of the disease. Herein, we propose a new self-priming hairpin-mediated isothermal amplification (SIAM) protocol enabling one-pot and ultrasensitive identification of SARS-CoV-2 in a multiplexed way. This approach works by targeting a specific RNA sequence with a self-priming hairpin (SP) probe and promoting continuously repeated extension and nicking reactions to produce numerous trigger molecules, which could specifically bind to molecular beacons (MBs) and produce fluorescent signals. Under an isothermal condition of 37 °C, this technique allowed for the simultaneous identification of the spike (S) and nucleocapsid (N) genes of SARS-CoV-2 down to single copy/μL levels. We further validated the practical diagnostic capabilities of the SIAM method by accurately testing 20 clinical samples with 100% sensitivity and specificity. The SIAM method has a lot of potential to be a reliable nucleic acid testing protocol to identify infections caused by a wide range of pathogens.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
Significance of focal electroencephalographic changes in the elderly.

E. Busse,W. Obrist

DOI: https://doi.org/10.1080/00325481.1963.11694811

1963-08-01

Postgraduate Medicine

Abstract:One-third of the population more than 60 years old will have an abnormal electroencephalogram of a focal type, consisting primarily of slow waves. This abnormality is usually maximal over the anterior temporal area and occurs more often on the left side of the brain. It is probably of vascular origin, although no consistent correlation has been established with physical or psychologic impairment. Its predilection for the left hemisphere is not related to cerebral dominance. The likelihood of seizures is not increased. The clinician is cautioned to avoid interpreting this finding as evidence of an expanding intracranial lesion.
Nucleic Acid Lateral Flow Assay Implemented with Isothermal Gene Amplification of SARS-CoV-2 RNA

Kangwuk Kyung,Hyojin Lee,Soo-Kyung Kim,Dong-Eun Kim

DOI: https://doi.org/10.3390/bios14120585

2024-12-03

Biosensors

Abstract:We developed a rapid and sensitive diagnostic platform that integrates isothermal viral gene amplification with a nucleic acid lateral flow assay (NALFA) to detect SARS-CoV-2 RNA. Isothermal gene amplification was performed by combining reverse transcription of viral RNA with recombinase polymerase amplification (RPA). In our diagnostic platform, DNA primers for the RPA reaction were modified by appending DNA tails, enabling the synthesis of tailed amplicon DNAs. These tailed amplicon DNAs were subsequently annealed to the complementary capture DNA probe affixed to the lateral flow strip during the NALFA of the reaction samples. The other side of each amplicon DNA tail was annealed to the reporter probe DNA conjugated with gold nanoparticles to visually detect the test line in the strip. This diagnostic platform reduces the time required to obtain readouts to within 1 h and can detect viral RNA concentrations as low as 3.1 cp/μL. Furthermore, when applied to nasopharyngeal clinical samples, our NALFA diagnostic platform yielded highly reliable molecular diagnostic readouts that were 100% consistent with the results of conventional RT-qPCR.

chemistry, analytical,nanoscience & nanotechnology,instruments & instrumentation
Tri-primer-enhanced Strand Exchange Amplification Combined with Rapid Lateral Flow Fluorescence Immunoassay to Detect SARS-CoV-2

Linlin Zhuang,Jiansen Gong,Ming Ma,Yongxin Ji,Peilong Tian,Xiuming Mei,Ning Gu,Yu Zhang

DOI: https://doi.org/10.1039/d1an00858g

2021-01-01

Abstract:The novel coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been surging rapidly around the world, which has exposed humanity to unprecedented economic, social and health impacts. To achieve efficient and accurate detection of SARS-CoV-2 on site, we developed and verified a rapid and sensitive fluorescence lateral flow immunoassay based on the innovative enhanced strand exchange amplification (ESEA-LFIA) in this study. With good amplification efficiency for short-sequence targets, ESEA is an ideal choice for the point-of-care testing of SARS-CoV-2 with a high mutation rate. ESEA reaction can be completed in one step and verified by restriction enzyme digestion. The design consisting of three working primers greatly improved the amplification efficiency. Amplification of the target sequences of the RdRP and N genes can be accomplished under the same reaction conditions, and does not require expensive instruments. The sensitivity of the ESEA-LFIA assay targeting the RdRP and N genes was 90 copies per μL and 70 copies per μL, respectively. Specificity tests showed that the novel assay can specifically detect SARS-CoV-2, and had no cross-reactivity with 9 closely-related human pathogenic coronaviruses and other common respiratory pathogens with similar clinical manifestations. The cutoff values of the RdRP and N gene assays are 11 and 12, respectively, and the assays can be completed within 1 h. The novel strategy proposed in this study is a sensitive and specific method for the rapid detection of SARS-CoV-2, and is suitable as an effective potential bioanalytical tool to respond to future regional or global outbreaks of emerging infectious pathogens with high mutation rates.
A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations

Yanan Zhao,Annie Lee,Kaelea Composto,Marcus H. Cunningham,Jose R. Mediavilla,Samantha Fennessey,Andre Corvelo,Kar Fai Chow,Michael Zody,Liang Chen,Barry N. Kreiswirth,David S. Perlin

DOI: https://doi.org/10.1080/22221751.2021.1929504

2021-01-01

Emerging Microbes & Infections

Abstract:Spike protein mutations E484K and N501Y carried by SARS-CoV-2 variants have been associated with concerning changes of the virus, including resistance to neutralizing antibodies and increased transmissibility. While the concerning variants are fast spreading in various geographical areas, identification and monitoring of these variants are lagging far behind, due in large part to the slow speed and insufficient capacity of viral sequencing. In response to the unmet need for a fast and efficient screening tool, we developed a single-tube duplex molecular assay for rapid and simultaneous identification of E484K and N501Y mutations from nasopharyngeal swab (NS) samples within 2.5 h from sample preparation to report. Using this tool, we screened a total of 1135 clinical NS samples collected from COVID patients at 8 hospitals within the Hackensack Meridian Health network in New Jersey between late December 2020 and March 2021. Our data revealed dramatic increases in the frequencies of both E484K and N501Y over time, underscoring the need for continuous epidemiological monitoring.
A Ligation/Recombinase Polymerase Amplification Assay for Rapid Detection of SARS-CoV−2

Pei Wang,Chao Ma,Xue Zhang,Lizhan Chen,Longyu Yi,Xin Liu,Qunwei Lu,Yang Cao,Song Gao

DOI: https://doi.org/10.3389/fcimb.2021.680728

IF: 6.073

2021-05-28

Frontiers in Cellular and Infection Microbiology

Abstract:The pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to more than 117 million reported cases and 2.6 million deaths. Accurate diagnosis technologies are vital for controlling this pandemic. Reverse transcription (RT)-based nucleic acid detection assays have been developed, but the strict sample processing requirement of RT has posed obstacles on wider applications. This study established a ligation and recombinase polymerase amplification (L/RPA) combined assay for rapid detection of SARS-CoV−2 on genes N and ORF1ab targeting the specific biomarkers recommended by the China CDC. Ligase-based strategies usually have a low-efficiency problem on RNA templates. This study has addressed this problem by using a high concentration of the T4 DNA ligase and exploiting the high sensitivity of RPA. Through selection of the ligation probes and optimization of the RPA primers, the assay achieved a satisfactory sensitivity of 10 1 viral RNA copies per reaction, which was comparable to RT-quantitative polymerase chain reaction (RT-qPCR) and other nucleic acid detection assays for SARS-CoV−2. The assay could be finished in less than 30 min with a simple procedure, in which the requirement for sophisticated thermocycling equipment had been avoided. In addition, it avoided the RT procedure and could potentially ease the requirement for sample processing. Once validated with clinical samples, the L/RPA assay would increase the practical testing availability of SARS-CoV-2. Moreover, the principle of L/RPA has an application potential to the identification of concerned mutations of the virus.

immunology,microbiology
Peptide Nucleic Acid Clamp‐Assisted Photothermal Multiplexed Digital PCR for Identifying SARS‐CoV‐2 Variants of Concern

Lexiang Zhang,Rokshana Parvin,Siyue Lin,Mingshuo Chen,Ruixuan Zheng,Qihui Fan,Fangfu Ye

DOI: https://doi.org/10.1002/advs.202306088

IF: 15.1

2024-01-21

Advanced Science

Abstract:PNA‐assisted NIR photothermal multiplexed dPCR technique recognizes SNPs at codons T19R, O614G, and H655Y of the spike protein gene, thereby discriminating Omicron and Delta variants from the wild‐type of SARS‐CoV‐2. Gelatin microcarriers loaded with GO nanocomposite assist PCR thermocycling under NIR irradiation, where three PNA probes target against SNPs to selectively amplify mutated templates via replication with multi‐color labeling. The unprecedented demand for variants diagnosis in response to the COVID‐19 epidemic has brought the spotlight onto rapid and accurate detection assays for single nucleotide polymorphisms (SNPs) at multiple locations. However, it is still challenging to ensure simplicity, affordability, and compatibility with multiplexing. Here, a novel technique is presented that combines peptide nucleic acid (PNA) clamps and near‐infrared (NIR)‐driven digital polymerase chain reaction (dPCR) to identify the Omicron and Delta variants. This is achieved by simultaneously identifying highly conserved mutated signatures at codons 19, 614, and 655 of the spike protein gene. By microfluidically introducing graphene‐oxide‐nanocomposite into the assembled gelatin microcarriers, they achieved a rapid temperature ramping‐up rate and switchable gel‐to‐sol phase transformation synchronized with PCR activation under NIR irradiation. Two sets of duplex PCR reactions, each classifying respective PNA probes, are emulsified in parallel and illuminated together using a homemade vacuum‐based droplet generation device and a programmable NIR control module. This allowed for selective amplification of mutant sequences due to single‐base‐pair mismatch with PNA blockers. Sequence‐recognized bioreactions and fluorescent‐color scoring enabled quick identification of variants. This technique achieved a detection limit of 5,100 copies and a 5‐fold quantitative resolution, which is promising to unfold minor differences and dynamic changes.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis

Akira Aoki,Yoko Mori,Yoshinori Okamoto,Hideto Jinno

DOI: https://doi.org/10.1016/j.jiac.2021.06.007

IF: 2.065

2021-09-01

Journal of Infection and Chemotherapy

Abstract:IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus causing coronavirus disease 2019 (COVID-19), has been expanding globally since late 2019. SARS-CoV-2, an RNA virus, has a genome sequence that can easily undergo mutation. Several mutated SARS-CoV-2 strains, including those with higher infectivity than others, have been reported. To reduce SARS-CoV-2 transmission, it is crucial to trace its infection sources. Here, we developed a simple, easy-to-use genotyping method to identify SARS-CoV-2 variants using a high-resolution melting (HRM) analysis.MethodsWe investigated five mutation sites, A23403G, G25563T, G26144T, T28144C, and G28882A, which are known strain determinants according to GISAID clades (L, S, V, G, GH, and GR).ResultsWe first employed synthetic DNA fragments containing the five characteristic sites for HRM analysis. All sequences clearly differentiated wild-type from mutant viruses. We then confirmed that RNA fragments were suitable for HRM analysis following reverse transcription. Human saliva did not negatively affect the HRM analysis, which supports the absence of a matrix effect.ConclusionsOur results indicate that this HRM-based genotyping method can identify SARS-CoV-2 variants. This novel assay platform potentially paves the way for accurate and rapid identification of SARS-CoV-2 infection sources.

pharmacology & pharmacy,infectious diseases
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology

Bo Pang,Jingyang Xu,Yanming Liu,Hanyong Peng,Wei Feng,Yiren Cao,Jinjun Wu,Huyan Xiao,Kanti Pabbaraju,Graham Tipples,Michael A. Joyce,Holly A. Saffran,D. Lorne Tyrrell,Hongquan Zhang,X. Chris Le

DOI: https://doi.org/10.1021/acs.analchem.0c04047

IF: 7.4

2020-11-26

Analytical Chemistry

Abstract:We have developed a single-tube assay for SARS-CoV-2 in patient samples. This assay combined advantages of reverse transcription (RT) loop-mediated isothermal amplification (LAMP) with clustered regularly interspaced short palindromic repeats (CRISPRs) and the CRISPR-associated (Cas) enzyme Cas12a. Our assay is able to detect SARS-CoV-2 in a single tube within 40 min, requiring only a single temperature control (62 °C). The RT-LAMP reagents were added to the sample vial, while CRISPR Cas12a reagents were deposited onto the lid of the vial. After a half-hour RT-LAMP amplification, the tube was inverted and flicked to mix the detection reagents with the amplicon. The sequence-specific recognition of the amplicon by the CRISPR guide RNA and Cas12a enzyme improved specificity. Visible green fluorescence generated by the CRISPR Cas12a system was recorded using a smartphone camera. Analysis of 100 human respiratory swab samples for the N and/or E gene of SARS-CoV-2 produced 100% clinical specificity and no false positive. Analysis of 50 samples that were detected positive using reverse transcription quantitative polymerase chain reaction (RT-qPCR) resulted in an overall clinical sensitivity of 94%. Importantly, this included 20 samples that required 30–39 threshold cycles of RT-qPCR to achieve a positive detection. Integration of the exponential amplification ability of RT-LAMP and the sequence-specific processing by the CRISPR-Cas system into a molecular assay resulted in improvements in both analytical sensitivity and specificity. The single-tube assay is beneficial for future point-of-care applications.This article has not yet been cited by other publications.

chemistry, analytical
Detection of SARS-CoV-2 and Its Mutated Variants via CRISPR-Cas13-Based Transcription Amplification

Yuxi Wang,Yong Zhang,Junbo Chen,Minjin Wang,Ting Zhang,Wenxin Luo,Yalun Li,Yangping Wu,Bo Zeng,Kaixiang Zhang,Ruijie Deng,Weimin Li

DOI: https://doi.org/10.1021/acs.analchem.0c04303

IF: 7.4

2021-01-29

Analytical Chemistry

Abstract:The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global health emergency, and its gene mutation and evolution further posed uncertainty of epidemic risk. Herein, we reported a light-up CRISPR-Cas13 transcription amplification method, which enables the detection of SARS-CoV-2 and its mutated variants. Sequence specificity was ensured by both the ligation process and Cas13a/crRNA recognition, allowing us to identify viral RNA mutation. Light-up RNA aptamer allows sensitive output of amplification signals via target-activated ribonuclease activity of CRISPR-Cas13a. The RNA virus assay has been designed to detect coronavirus, SARS-CoV-2, Middle East respiratory syndrome (MERS), and SARS, as well as the influenza viruses such as, H1N1, H7N9, and H9N2. It was accommodated to sense as low as 82 copies of SARS-CoV-2. Particularly, it allowed us to strictly discriminate key mutation of the SARS-CoV-2 variant, D614G, which may induce higher epidemic and pathogenetic risk. The proposed RNA virus assays are promising for point-of-care monitoring of SARS-CoV-2 and its risking variants.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04303?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04303</a>.Oligonucleotide sequences; different assays for the detection of SARS-CoV-2; gene sequences of SARS-CoV-2 (wild), SARS-CoV-2 (D614G mutated), SARS and MERS pseudovirus; plasmid vector for constructing pseudovirus; working flow to prepare SARS-CoV-2 contaminated food packages and frozen belt fish samples; detection of E gene of coronavirus species; the effect of locus sites of mutation on the specificity; the effect of recognition sequences of mutation on the specificity; discrimination rates via ligation-based recognition or the integration of ligation and Cas13/crRNA recognition; optimization of the ratio of Cas13a to crRNA; real-time analysis of Cas13a-crRNA induced cleavage of light-up RNA aptamer; amplification curves of N genes of SARS-CoV-2 from clinical throat swab samples; and sequencing of SARS-CoV-2 in clinical throat swab samples (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04303/suppl_file/ac0c04303_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

chemistry, analytical
A Simplified Sanger Sequencing Method for Detection of Relevant SARS-CoV-2 Variants

Felice Deminco,Celia Pedroso,Jean Tadeu,Andreas Stoecker,Eduardo Netto,Carlos Brites,Sara N. Vaz,Daniele S. Santana,Sueli M. Vieira

DOI: https://doi.org/10.3390/diagnostics12112609

IF: 3.6

2022-10-28

Diagnostics

Abstract:Molecular surveillance of the new coronavirus through new genomic sequencing technologies revealed the circulation of important variants of SARS-CoV-2. Sanger sequencing has been useful in identifying important variants of SARS-CoV-2 without the need for whole-genome sequencing. A sequencing protocol was constructed to cover a region of 1000 base pairs, from a 1120 bp product generated after a two-step RT-PCR assay in samples positive for SARS-CoV-2. Consensus sequence construction and mutation identification were performed. Of all 103 samples sequenced, 69 contained relevant variants represented by 20 BA.1, 13 delta, 22 gamma, and 14 zeta, identified between June 2020 and February 2022. All sequences found were aligned with representative sequences of the variants. Using the Sanger sequencing methodology, we were able to develop a more accessible protocol to assist viral surveillance with a more accessible platform.

medicine, general & internal
Intraoperative pulmonary oedema in a young cocaine smoker

P. Singh,I. Dimich,A. Shamsi

DOI: https://doi.org/10.1007/BF03010938

1994-10-01

Abstract:
A CRISPR/Cas12 trans-cleavage reporter enabling label-free colorimetric detection of SARS-CoV-2 and its variants

Hansol Kim,Hyowon Jang,Jayeon Song,Sang Mo Lee,Seoyoung Lee,Hyung-Jun Kwon,Sunjoo Kim,Taejoon Kang,Hyun Gyu Park

DOI: https://doi.org/10.1016/j.bios.2024.116102

IF: 12.545

2024-02-06

Biosensors and Bioelectronics

Abstract:We present a label-free colorimetric CRISPR/Cas-based method enabling affordable molecular diagnostics for SARS-CoV-2. This technique utilizes 3,3′-diethylthiadicarbocyanine iodide (DISC 2 (5)) which exhibits a distinct color transition from purple to blue when it forms dimers by inserting into the duplex of the thymidine adenine (TA) repeat sequence. Loop-mediated isothermal amplification (LAMP) or recombinase polymerase amplification (RPA) was used to amplify target samples, which were subsequently subjected to the CRISPR/Cas12a system. The target amplicons would activate Cas12a to degrade nearby TA repeat sequences, preserving DISC 2 (5) in its free form to display purple as opposed to blue in the absence of the target. Based on this design approach, SARS-CoV-2 RNA was colorimetrically detected very sensitively down to 2 copies/μL, and delta and omicron variants of SARS-CoV-2 were also successfully identified. The practical diagnostic utility of this method was further validated by reliably identifying 179 clinical samples including 20 variant samples with 100% clinical sensitivity and specificity. This technique has the potential to become a promising CRISPR-based colorimetric platform for molecular diagnostics of a wide range of target pathogens.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing

Y Kim,T Noh,S Lee,Y Kim,D Prakash,K Lee

DOI: https://doi.org/10.1093/clinchem/hvad097.556

IF: 12.114

2023-09-27

Clinical Chemistry

Abstract:Abstract Background Currently, various diagnostic kits are being developed to aid in the rapid diagnosis or detection of SARS-CoV-2, but viruses continue to evolve through mutations resulting in phenotypic changes such as increased infectivity and pathogenicity, or vaccine evasion. Over time, such alterations in sequence may also occur at the annealing sites of the primers and probes in the diagnostic kit, leading to false-negative results. To prevent this, a continuous mutation monitoring is required. The authors performed SARS-CoV-2 Whole Genome Sequencing (WGS) and then compared and monitored the difference between actual experimental and public data from the National Center for Biotechnology Information (NCBI) datasets for each mutant strain. Methods WGS was performed by using GridION (Oxford Nanopore Technologies, UK) on 1500 nasopharyngeal swab SARS-CoV-2 positive samples requested for testing at SCL from January 2020 to December 2022. Experimental data were aligned through epi2me and analyzed using the Nextclade platform (Fig. 1A). For public data, 119 sequences reported in Korea (Fig. 1B) were retrieved from the NCBI database, reanalyzed using Nextclade platform, and compared. Results In numerous samples tested, mutation, insertion, and deletion were found to occur over time. In particular, in the case of Omicron subvariants, a common Gap (region 1; Gap: 11288–11296, region 2; Gap: 28362–28370) were identified in orf1ab (RdRP), the target gene for the majority of existing diagnostic kits, and in N gene (Fig. 1). Therefore, while designing a diagnostic kit, this region should not be included in the annealing site. Conclusion In order to maintain an effective diagnosis and quarantine system for COVID-19, mutations affecting the annealing site of primers and probes must be identified through a continuous genome monitoring. The results obtained from the continuous genome monitoring can be utilized to upgrade the existing commercially available kits as well as to develop new kits.

medical laboratory technology
Smartphone-Based SARS-CoV-2 and Variants Detection System using Colorimetric DNAzyme Reaction Triggered by Loop-Mediated Isothermal Amplification (LAMP) with Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Jayeon Song,Baekdong Cha,Jeong Moon,Hyowon Jang,Sunjoo Kim,Jieun Jang,Dongeun Yong,Hyung-Jun Kwon,In-Chul Lee,Eun-Kyung Lim,Juyeon Jung,Hyun Gyu Park,Taejoon Kang

DOI: https://doi.org/10.1021/acsnano.2c04840

IF: 17.1

2022-06-24

ACS Nano

Abstract:Coronavirus disease (COVID-19) has affected people for over two years. Moreover, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has raised concerns regarding its accurate diagnosis. Here, we report a colorimetric DNAzyme reaction triggered by loop-mediated isothermal amplification (LAMP) with clustered regularly interspaced short palindromic repeats (CRISPR), referred to as DAMPR assay for detecting SARS-CoV-2 and variants genes with attomolar sensitivity...

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology

Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.

Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

RT-LAMP Assay Combining Multi-Fluorescent Probes for SARS-CoV-2 RNA Detection and Variant Differentiation

Enhanced selective discrimination of point-mutated viral RNA through false amplification regulatory direct insertion in rolling circle amplification

Rapid and Accurate Detection of Three Genes in SARS-CoV-2 Using RT-LAMP Method

A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2

One-pot, ultrasensitive, and multiplex detection of SARS-CoV-2 genes utilizing self-priming hairpin-mediated isothermal amplification

Significance of focal electroencephalographic changes in the elderly.

Nucleic Acid Lateral Flow Assay Implemented with Isothermal Gene Amplification of SARS-CoV-2 RNA

Tri-primer-enhanced Strand Exchange Amplification Combined with Rapid Lateral Flow Fluorescence Immunoassay to Detect SARS-CoV-2

A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations

A Ligation/Recombinase Polymerase Amplification Assay for Rapid Detection of SARS-CoV−2

Peptide Nucleic Acid Clamp‐Assisted Photothermal Multiplexed Digital PCR for Identifying SARS‐CoV‐2 Variants of Concern

Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis

Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology

Detection of SARS-CoV-2 and Its Mutated Variants via CRISPR-Cas13-Based Transcription Amplification

A Simplified Sanger Sequencing Method for Detection of Relevant SARS-CoV-2 Variants

Intraoperative pulmonary oedema in a young cocaine smoker

A CRISPR/Cas12 trans-cleavage reporter enabling label-free colorimetric detection of SARS-CoV-2 and its variants

B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing

Smartphone-Based SARS-CoV-2 and Variants Detection System using Colorimetric DNAzyme Reaction Triggered by Loop-Mediated Isothermal Amplification (LAMP) with Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)